Annual Operating Profit
-$30.41 M
+$57.49 M+65.40%
31 December 2022
Summary:
Catalyst Biosciences annual operaing income is currently -$30.41 million, with the most recent change of +$57.49 million (+65.40%) on 31 December 2022. During the last 3 years, it has risen by +$57.49 million (+65.40%).CBIO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$1.62 M
+$920.00 K+36.18%
30 September 2023
Summary:
Catalyst Biosciences quarterly operating income is currently -$1.62 million, with the most recent change of +$920.00 thousand (+36.18%) on 30 September 2023.CBIO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$13.55 M
+$3.54 M+20.73%
30 September 2023
Summary:
Catalyst Biosciences TTM operating income is currently -$13.55 million, with the most recent change of +$3.54 million (+20.73%) on 30 September 2023.CBIO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +65.4% | +92.0% | +84.6% |
| 5 y5 years | +46.9% | +88.4% | +76.3% |
CBIO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -331.8% | -109.8% | -173.9% |
Catalyst Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.62 M(-36.2%) | -$13.55 M(-20.7%) |
| June 2023 | - | -$2.54 M(-44.2%) | -$17.09 M(-15.7%) |
| Mar 2023 | - | -$4.56 M(-5.5%) | -$20.26 M(-33.4%) |
| Dec 2022 | -$30.41 M(-65.4%) | -$4.83 M(-6.6%) | -$30.41 M(-33.7%) |
| Sept 2022 | - | -$5.17 M(-9.6%) | -$45.90 M(-30.4%) |
| June 2022 | - | -$5.71 M(-61.1%) | -$65.96 M(-17.7%) |
| Mar 2022 | - | -$14.70 M(-27.6%) | -$80.16 M(-8.8%) |
| Dec 2021 | -$87.89 M(+53.2%) | -$20.31 M(-19.5%) | -$87.89 M(+1.7%) |
| Sept 2021 | - | -$25.23 M(+26.7%) | -$86.42 M(+11.8%) |
| June 2021 | - | -$19.91 M(-11.2%) | -$77.29 M(+3.4%) |
| Mar 2021 | - | -$22.44 M(+19.1%) | -$74.74 M(+30.3%) |
| Dec 2020 | -$57.37 M(+0.2%) | -$18.84 M(+17.0%) | -$57.37 M(+9.2%) |
| Sept 2020 | - | -$16.10 M(-7.3%) | -$52.52 M(+5.9%) |
| June 2020 | - | -$17.36 M(+242.6%) | -$49.61 M(+6.4%) |
| Mar 2020 | - | -$5.07 M(-63.8%) | -$46.63 M(-18.6%) |
| Dec 2019 | -$57.28 M(+69.3%) | -$13.99 M(+6.0%) | -$57.28 M(+4.2%) |
| Sept 2019 | - | -$13.20 M(-8.2%) | -$54.97 M(+9.7%) |
| June 2019 | - | -$14.38 M(-8.5%) | -$50.12 M(+17.0%) |
| Mar 2019 | - | -$15.71 M(+34.5%) | -$42.86 M(+26.7%) |
| Dec 2018 | -$33.82 M(+55.0%) | -$11.68 M(+40.0%) | -$33.82 M(+20.9%) |
| Sept 2018 | - | -$8.35 M(+17.3%) | -$27.97 M(+9.7%) |
| June 2018 | - | -$7.11 M(+6.5%) | -$25.50 M(+4.8%) |
| Mar 2018 | - | -$6.68 M(+14.6%) | -$24.33 M(+11.5%) |
| Dec 2017 | -$21.82 M(+6.9%) | -$5.83 M(-0.8%) | -$21.82 M(+2.9%) |
| Sept 2017 | - | -$5.88 M(-1.1%) | -$21.21 M(+0.8%) |
| June 2017 | - | -$5.94 M(+42.5%) | -$21.05 M(+5.1%) |
| Mar 2017 | - | -$4.17 M(-20.1%) | -$20.02 M(-2.0%) |
| Dec 2016 | -$20.42 M(+47.9%) | -$5.22 M(-8.6%) | -$20.42 M(+2.7%) |
| Sept 2016 | - | -$5.71 M(+16.2%) | -$19.88 M(+10.1%) |
| June 2016 | - | -$4.92 M(+7.5%) | -$18.06 M(+9.2%) |
| Mar 2016 | - | -$4.57 M(-2.4%) | -$16.53 M(-6.2%) |
| Dec 2015 | -$13.80 M(-53.0%) | -$4.68 M(+20.6%) | -$17.63 M(+1.6%) |
| Sept 2015 | - | -$3.88 M(+14.6%) | -$17.35 M(-6.0%) |
| June 2015 | - | -$3.39 M(-40.2%) | -$18.46 M(-20.8%) |
| Mar 2015 | - | -$5.67 M(+28.4%) | -$23.31 M(-20.7%) |
| Dec 2014 | -$29.40 M(-37.7%) | -$4.41 M(-11.5%) | -$29.40 M(-23.2%) |
| Sept 2014 | - | -$4.99 M(-39.5%) | -$38.29 M(-17.6%) |
| June 2014 | - | -$8.24 M(-29.9%) | -$46.45 M(-8.4%) |
| Mar 2014 | - | -$11.76 M(-11.7%) | -$50.70 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$47.22 M(+968.2%) | -$13.31 M(+1.2%) | -$47.22 M(-3.2%) |
| Sept 2013 | - | -$13.15 M(+5.3%) | -$48.76 M(+11.5%) |
| June 2013 | - | -$12.49 M(+50.9%) | -$43.71 M(+197.8%) |
| Mar 2013 | - | -$8.27 M(-44.3%) | -$14.68 M(+232.1%) |
| Dec 2012 | -$4.42 M(-54.6%) | -$14.85 M(+83.4%) | -$4.42 M(-1629.4%) |
| Sept 2012 | - | -$8.10 M(-148.9%) | $289.00 K(-130.6%) |
| June 2012 | - | $16.55 M(+733.1%) | -$944.00 K(-95.3%) |
| Mar 2012 | - | $1.99 M(-119.6%) | -$20.06 M(+105.9%) |
| Dec 2011 | -$9.74 M(-174.3%) | -$10.14 M(+8.7%) | -$9.74 M(+918.3%) |
| Sept 2011 | - | -$9.33 M(+262.9%) | -$957.00 K(-108.9%) |
| June 2011 | - | -$2.57 M(-120.9%) | $10.79 M(-41.1%) |
| Mar 2011 | - | $12.30 M(-1006.6%) | $18.33 M(+39.7%) |
| Dec 2010 | $13.12 M(-132.5%) | -$1.36 M(-156.1%) | $13.12 M(-207.9%) |
| Sept 2010 | - | $2.42 M(-51.3%) | -$12.15 M(-9.1%) |
| June 2010 | - | $4.97 M(-29.9%) | -$13.36 M(-52.6%) |
| Mar 2010 | - | $7.09 M(-126.6%) | -$28.18 M(-30.1%) |
| Dec 2009 | -$40.33 M(+43.3%) | -$26.62 M(-2311.1%) | -$40.32 M(+106.3%) |
| Sept 2009 | - | $1.20 M(-112.2%) | -$19.55 M(-32.4%) |
| June 2009 | - | -$9.85 M(+95.1%) | -$28.92 M(+9.1%) |
| Mar 2009 | - | -$5.05 M(-13.6%) | -$26.50 M(-5.9%) |
| Dec 2008 | -$28.14 M(-11.4%) | -$5.85 M(-28.4%) | -$28.14 M(-9.1%) |
| Sept 2008 | - | -$8.16 M(+9.8%) | -$30.95 M(-0.8%) |
| June 2008 | - | -$7.43 M(+10.9%) | -$31.19 M(-5.0%) |
| Mar 2008 | - | -$6.70 M(-22.6%) | -$32.83 M(+3.3%) |
| Dec 2007 | -$31.77 M(+7770.1%) | -$8.65 M(+3.0%) | -$31.77 M(+351.3%) |
| Sept 2007 | - | -$8.40 M(-7.4%) | -$7.04 M(+64.2%) |
| June 2007 | - | -$9.07 M(+60.8%) | -$4.29 M(+704.7%) |
| Mar 2007 | - | -$5.64 M(-135.1%) | -$533.00 K(+32.0%) |
| Dec 2006 | -$403.70 K(-98.7%) | $16.08 M(-384.5%) | -$403.70 K(-98.3%) |
| Sept 2006 | - | -$5.65 M(+6.3%) | -$23.26 M(-6.1%) |
| June 2006 | - | -$5.32 M(-3.6%) | -$24.77 M(-10.9%) |
| Mar 2006 | - | -$5.51 M(-18.6%) | -$27.80 M(-7.2%) |
| Dec 2005 | -$29.94 M(+22.7%) | -$6.78 M(-5.5%) | -$29.94 M(+29.2%) |
| Sept 2005 | - | -$7.17 M(-14.0%) | -$23.17 M(+44.8%) |
| June 2005 | - | -$8.34 M(+8.9%) | -$16.00 M(+108.9%) |
| Mar 2005 | - | -$7.66 M | -$7.66 M |
| Dec 2004 | -$24.39 M(+21.6%) | - | - |
| Dec 2003 | -$20.06 M(-4.5%) | - | - |
| Dec 2002 | -$21.00 M(+140.0%) | - | - |
| Dec 2001 | -$8.75 M | - | - |
FAQ
- What is Catalyst Biosciences annual operaing income?
- What is the all time high annual operating profit for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Catalyst Biosciences?
- What is Catalyst Biosciences TTM operating income?
- What is the all time high TTM operating profit for Catalyst Biosciences?
What is Catalyst Biosciences annual operaing income?
The current annual operating profit of CBIO is -$30.41 M
What is the all time high annual operating profit for Catalyst Biosciences?
Catalyst Biosciences all-time high annual operaing income is $13.12 M
What is Catalyst Biosciences quarterly operating income?
The current quarterly operating profit of CBIO is -$1.62 M
What is the all time high quarterly operating profit for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly operating income is $16.55 M
What is Catalyst Biosciences TTM operating income?
The current TTM operating profit of CBIO is -$13.55 M
What is the all time high TTM operating profit for Catalyst Biosciences?
Catalyst Biosciences all-time high TTM operating income is $18.33 M